Kim Gariepy

Kim Gariepy is an experienced professional in the pharmaceutical and biotechnology industries, currently serving as a Board Member and Treasurer for NAMI San Mateo County. At Gilead Sciences, Kim holds the position of Executive Director in Oncology Marketing. Previously, Kim was the Head of US Marketing for Imbruvica within the Pharmacyclics division at AbbVie and served as Chief of Staff for the Hematology & Rare Disease Business Unit at Shire, now part of Takeda. Additional roles include Senior Director of Marketing and Launch Lead for Mydayis in Neuroscience, Marketing Director for SHP465 pre-launch planning, and Marketing Manager for Immunology at Abbott. Kim's academic background includes an MBA from McGill University and a Bachelor of Business Administration in Finance from HEC Montréal.